DocSym
β
Searchsearch
Search
(P91.2) Neonatal cerebral leukomalacia
More details coming soon
164 635 in individuals diagnosis neonatal cerebral leukomalacia confirmed
7 386 deaths with diagnosis neonatal cerebral leukomalacia
5% mortality rate associated with the disease neonatal cerebral leukomalacia
Diagnosis neonatal cerebral leukomalacia is diagnosed Men are 17.66% more likely than Women
96 853
Men receive the diagnosis neonatal cerebral leukomalacia
3 077 (3.2 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
67 782
Women receive the diagnosis neonatal cerebral leukomalacia
4 309 (6.4 %)Died from this diagnosis.
Risk Group for the Disease neonatal cerebral leukomalacia - Men and Women aged 0
In Men diagnosis is most often set at age 0-5
Less common in men the disease occurs at Age 5-95+Less common in women the disease occurs at Age 10-19, 25-29, 35-95+
In Women diagnosis is most often set at age 0-9, 20-24, 30-34
Disease Features neonatal cerebral leukomalacia
Absence or low individual and public risk
Neonatal cerebral leukomalacia - what does this mean
Neonatal cerebral leukomalacia is a medical condition in which the white matter of the brain is damaged due to lack of oxygen during delivery, resulting in neurological impairments such as cerebral palsy, seizures, and developmental delays.
What happens during the disease - neonatal cerebral leukomalacia
Neonatal cerebral leukomalacia is a neurological disorder that results from the death of white matter in the brain of a newborn. it is typically caused by a lack of oxygen to the brain, leading to the death of oligodendrocytes, which are responsible for the insulation of nerve cells in the brain. this lack of insulation can lead to impaired communication between nerve cells, leading to a wide range of neurological deficits.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Evaluation of medical history and physical examination
- Neurological examination
- MRI scan of the brain
- CT scan of the brain
- Ultrasound of the brain
- Cerebrospinal fluid analysis
- Blood tests
- Electroencephalogram (EEG)
Treatment and Medical Assistance
Main goal of the treatment: Reduce the risk of long-term neurological and developmental issues associated with neonatal cerebral leukomalacia.
- Provide supportive care to ensure the baby is receiving adequate nutrition and hydration.
- Monitor the baby's vital signs and oxygen levels.
- Administer medications to reduce inflammation.
- Provide physical and occupational therapy.
- Encourage frequent rest periods.
- Provide emotional support for the family.
- Monitor the baby's development and adjust treatment as needed.
18 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Neonatal cerebral leukomalacia - Prevention
Neonatal cerebral leukomalacia can be prevented by ensuring pregnant women have access to prenatal care and receive proper nutrition, avoiding smoking and alcohol consumption, and avoiding exposure to environmental toxins. additionally, proper monitoring of the baby during labor and delivery is important to ensure timely delivery and appropriate oxygen levels.